Product Images Novavax Covid-19 Vaccine, Adjuvanted
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Novavax Covid-19 Vaccine, Adjuvanted NDC 80631-100 by Novavax, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NOVAVAX 1
Novavax COVID-19 Vaccine is a suspension for intramuscular injection that comes in 10 multi-dose vials with each vial containing 10 doses of 0.5 mL. It is intended for emergency use authorization. See the FDA-authorized Fact Sheets for additional information and dosage. It must be stored at 2-8°C (35 to 46°F) and should not be frozen. After opening, it should be held between 2-25°C (36-77°F) and discarded after 6 hours. Protect from light. The text contains some errors and misspelled words.*
NOVAVAX 2
This is a description of Novavax COVID-19 Vaccine, Adjuvanted, which is a suspension for intramuscular injection. It comes in a multi-dose vial with 10 doses of 0.5ml. It is intended for use under Emergency Use Authorization and should be stored at 2 to 8°C (36 to 46°F) without freezing. After the first puncture, it should be held at 2 to 25°C (36 to 77°F) for up to 6 hours, and should be discarded after that time. This vaccine does not contain a preservative, and it should be protected from light. The manufacturer is Novavax, Inc., based in Gaithersburg, MD 20878. No further information is available.*
NOVAVAX 3
NOVAVAX 4
NOVAVAX 5
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.